← Leaderboards
Babak Behsaz
Exai Bio, Inc.
$426,969
Attributed
$1,280,908
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$1,280,908 · 1
By mechanism
R44$1,280,908 · 1
Top collaborators
- Babak Alipanahi1 shared
- Sandip Pravin Patel1 shared
Most similar at Exai Bio, Inc.
Same institution · by research overlap
- Babak Alipanahi$426,969
- Sandip Pravin Patel$426,969
Others in their field
Other Rising Stars on “Adenocarcinoma”
- Edwin Manuel · Beckman Research Institute/City Of Hope$3,382,655
- Reeder McNeil Robinson · Leukogene Therapeutics, Inc.$2,940,211
- Pingping Hou · Rutgers Biomedical And Health Sciences$2,730,524
- Alice Chia- Chi Wei · Sloan-Kettering Inst Can Research$2,617,533
- Evan Chen Lien · Massachusetts Institute Of Technology$2,399,497
- Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research$2,300,843
Research focus
AdenocarcinomaAffectAftercareAlgorithmsAmerican Association Of Cancer ResearchAmerican Society Of Clinical OncologyArtificial Intelligence ModelBiological MarkersBloodCancer CareCancer CellCancer CenterCancer DetectionCancer DiagnosisCancer EtiologyCancer PatientCancer TherapyCare OutcomesCessation Of LifeCharacteristicsClinical ResearchClinical SensitivityCloud BasedAccreditation